Akero Therapeutics
Small-molecule therapeutics for metabolic dysfunction-associated steatohepatitis (MASH)
- Sector
- Biotech
- Headquarters
- South San Francisco, CA
- Founded
- 2017
- Latest Form D
- $45.5M, Dec 2018
- Total capital
- $45.5M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $45.5M
- 1 Form D · last Dec 2018
- 94 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 1
- 8 pending · first 2026
- Rank in peer group#481 of 1449
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 1st filing$45.5M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 1449 peers
Line = medianBiotech · Molecule
- Granted patents#481 · top 33%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Aaron KantoffDirectorNamed in SEC Form D filings
- Aaron RoystonDirectorNamed in SEC Form D filings
- Andrew ChengExecutive Officer, DirectorNamed in SEC Form D filings
- Graham WalmsleyDirectorNamed in SEC Form D filings
- Jonathan YoungExecutive OfficerNamed in SEC Form D filings
- Kevin BittermanDirectorNamed in SEC Form D filings
Show all 7 people
- Mark IwickiDirectorNamed in SEC Form D filings
What it has protected
USPTO · 1 granted of 9- GrantedInjection DeviceUSPTOUS D1,128,904
- PendingFGF21 Mutant PolypeptidesUSPTOApplication 19110673
- PendingPharmaceutical Compositions Of EfruxiferminUSPTOApplication 18700597
Show all 9 patent records
- Injection DeviceJun 2, 2026 · US D1,128,904Granted
- FGF21 Mutant PolypeptidesMar 19, 2026 · Application 19110673Pending
- Pharmaceutical Compositions Of EfruxiferminOct 2, 2025 · Application 18700597Pending
- Plunger Rod Assembly Configured To Reduce Use Error Associated With Operation Of A Medical Device Including The Plunger Rod AssemblyJun 12, 2025 · Application 18974338Pending
- FGF21 Mutant PolypeptidesApplication 63405758Pending
- Pharmaceutical Compositions Of EfruxiferminApplication 63255286Pending
- Plunger Rod Assembly Configured To Reduce Use Error Associated With Operation Of An Injection Device Including The Plunger Rod AssemblyApplication 63608029Pending
- FGF21 Mutant PolypeptidesApplication PCTUS2023073867Pending
- Pharmaceutical Compositions Of EfruxiferminApplication PCTUS2022077968Pending
Related companies, and why
- Clene Nanomedicine, Inc.Similar federal contract value in Biotech · null in contracts
- TNA Therapeutics Inc.Similar federal contract value in Biotech · null in contracts
- SynlogicSimilar federal contract value in Biotech · null in contracts
- Pionyr ImmunotherapeuticsSimilar federal contract value in Biotech · null in contracts
- Nkarta, Inc.Similar federal contract value in Biotech · null in contracts
- GLOBEIMMUNE INCSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .